Effect of Sertraline versus Saffron capsule (SaffroMood) on the treatment of major depressive disorder in elderly
Phase 2
Recruiting
- Conditions
- Major depressive disorder, recurrentMajor depressive disorder.
- Registration Number
- IRCT20120215009014N204
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Age of 60 to 90 years
Major depressive disorder
Exclusion Criteria
Thyroid disorder
Psychiatric disorders such as bipolar disorder and schizophrenia
Drug abuse in the past 3 months
Intention to suicide in the past year
Using anti-depression drugs in the past month
Electroconvulsive therapy in the past 2 months
Using anticoagulant or NSAIDS
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the signs and symptoms of major depressive disorder. Timepoint: Before and 6 weeks after treatment. Method of measurement: Using Hamilton questionnaire.
- Secondary Outcome Measures
Name Time Method